» Articles » PMID: 39055462

Extracorpeal Membrane Oxygenation in a Cystic Fibrosis Patient With Septic Shock Due to Methicillin-Resistant Staphylococcus Aureus

Overview
Journal Cureus
Date 2024 Jul 26
PMID 39055462
Authors
Affiliations
Soon will be listed here.
Abstract

This report presents the case of an 18-year-old male with cystic fibrosis (CF) who developed septic shock due to methicillin-resistant (MRSA) bacteremia. He had a history of poor nutritional status and uncontrolled CF-related diabetes, both contributing to his rapidly declining condition. Despite aggressive treatment, including extracorporeal membrane oxygenation, his hospital course continued to deteriorate, including worsening respiratory failure and the need for lower extremity amputation secondary to ischemia. Ultimately, the decision to withdraw life support was made after it was determined the patient had unrecoverable respiratory failure. Our goal in presenting this case is to demonstrate the serious consequences of MRSA infection in patients with CF, who are often severely immunocompromised, and to emphasize the need for early detection and aggressive intervention among patients of this group.

References
1.
Estrada-Veras J, Groninger H . Palliative care for patients with cystic fibrosis #265. J Palliat Med. 2013; 16(4):446-7. PMC: 3654821. DOI: 10.1089/jpm.2013.9515. View

2.
Blanchard A, Waters V . Microbiology of Cystic Fibrosis Airway Disease. Semin Respir Crit Care Med. 2019; 40(6):727-736. PMC: 7117079. DOI: 10.1055/s-0039-1698464. View

3.
Hayes Jr D, Kopp B, Preston T, Kirkby S, Tobias J, Papadimos T . Survival of patients with cystic fibrosis on ECMO: analysis of the Extracorporeal Life Support Organization Registry. Int J Clin Exp Med. 2014; 7(5):1370-2. PMC: 4073758. View

4.
Scoffone V, Chiarelli L, Trespidi G, Mentasti M, Riccardi G, Buroni S . Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches. Front Microbiol. 2017; 8:1592. PMC: 5572248. DOI: 10.3389/fmicb.2017.01592. View

5.
Cunningham F, Caldwell E, Mayer-Hamblett N, Goss C, Muhlebach M . Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial. ERJ Open Res. 2022; 8(4). PMC: 9720546. DOI: 10.1183/23120541.00190-2022. View